MAPT and tauopathy: Taken together, these data show that the removal of soluble pathogenic tau aggregates from the brain by a single course of TOMA treatment effectively restores endothelium-dependent vascular function in P301S(PS19) at advanced stages of tauopathy (Fig. 6A, B).